Literature DB >> 1735085

Expression of MDR1 and glutathione S transferase-pi genes and chemosensitivities in human gastrointestinal cancer.

T Satta1, K Isobe, M Yamauchi, I Nakashima, H Takagi.   

Abstract

The relationship was analyzed between drug resistance and MDR1 (with MDR signifying multiple drug resistance) and glutathione S transferase-pi (GST-pi) gene expression in four stomach and four colon cancer cell lines. Northern blot analysis by pmdr1 probe showed that stomach cancer cell lines had no detectable level of MDR1 mRNA expression. By contrast, some levels of MDR1 mRNA expression were found in two colon cancer cell lines, indicating doxorubicin resistance. To examine the MDR1 mRNA in each cell level, in situ hybridization was used. It was found that all colon cell lines and two stomach cell lines had more silver grains per cell than KB cells (a human KB kidney epidermoid carcinoma cell line). However, the number of silver grains in each cell was heterogeneous in the colon and stomach cell lines. Low-level MDR1 mRNA expression could be detected even in cell lines without MDR1 mRNA expression by northern blot hybridization. These results suggest the possibility that all gastrointestinal cell lines can acquire multiple drug resistance. In addition, all examined gastrointestinal cell lines had high GST-pi mRNA expression. This GST-pi gene expression shows cisplatin resistance in the examined cell lines. Heterogeneity of GST-pi mRNA expression also was shown at the cellular level.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735085     DOI: 10.1002/1097-0142(19920215)69:4<941::aid-cncr2820690418>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  COUP-TFII promotes colorectal carcinoma resistance to doxorubicin involving inhibition of epithelial-mesenchymal transition [corrected].

Authors:  Xiang Wang; Rui Jiang; Enhai Cui; Wenming Feng; Huihui Guo; Donghua Gu; Chengwu Tang; Tao Xue; Ying Bao
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

2.  Characterization of the molecular forms of glutathione S-transferase P1 in human gastric cancer cells (Kato III) and in normal human erythrocytes.

Authors:  Perungavar N Ranganathan; Richard Whalen; Thomas D Boyer
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

Review 3.  Glutathione-related enzymes, glutathione and multidrug resistance.

Authors:  J A Moscow; K H Dixon
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  Expression of glutathione-S-transferases alpha and pi in gastric cancer: a correlation with cisplatin resistance.

Authors:  Y Kodera; K Isobe; M Yamauchi; K Kondo; S Akiyama; K Ito; I Nakashima; H Takagi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 5.  Molecular chess? Hallmarks of anti-cancer drug resistance.

Authors:  Ian A Cree; Peter Charlton
Journal:  BMC Cancer       Date:  2017-01-05       Impact factor: 4.430

6.  Role of GSTM1 Copy Number Variant in the Prognosis ofzzm321990Thai Colorectal Cancer Patients Treated with 5-FU-basedzzm321990Chemotherapy

Authors:  Tanett Pongtheerat; Pensri Saelee
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

Review 7.  Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer.

Authors:  Mohamed Haider; Amr Elsherbeny; Valeria Pittalà; Valeria Consoli; Maha Ali Alghamdi; Zahid Hussain; Ghalia Khoder; Khaled Greish
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

8.  Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells.

Authors:  Xianling Guo; Nannan Ma; Jin Wang; Jianrui Song; Xinxin Bu; Yue Cheng; Kai Sun; Haiyan Xiong; Guocheng Jiang; Baihe Zhang; Mengchao Wu; Lixin Wei
Journal:  BMC Cancer       Date:  2008-12-18       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.